Regulation of blood vessels by prolactin and vasoinhibins.
Adv Exp Med Biol
; 846: 83-95, 2015.
Article
in En
| MEDLINE
| ID: mdl-25472535
ABSTRACT
Prolactin (PRL) stimulates the growth of new blood vessels (angiogenesis) either directly through actions on endothelial cells or indirectly by upregulating proangiogenic factors like vascular endothelial growth factor (VEGF). Moreover, PRL acquires antiangiogenic properties after undergoing proteolytic cleavage to vasoinhibins, a family of PRL fragments (including 16 kDa PRL) with potent antiangiogenic, vasoconstrictive, and antivasopermeability effects. In view of the opposing actions of PRL and vasoinhibins, the regulation of the proteases responsible for specific PRL cleavage represents an efficient mechanism for controlling blood vessel growth and function. This review briefly describes the vascular actions of PRL and vasoinhibins, and addresses how their interplay could help drive biological effects of PRL in the context of health and disease.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prolactin
/
Blood Vessels
/
Angiogenesis Inhibitors
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Adv Exp Med Biol
Year:
2015
Document type:
Article